---

Can favipiravir help in coronavirus treatment?

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Shaik Ali Hassan*, Sumit Bhateja, Geetika Arora, Francis Prathyusha

Volume : 5, Issue : 2, Year : 2020

Article Page : 73-76

https://doi.org/10.18231/j.ijcaap.2020.016

Suggest article by email

Get Permission

Abstract

COVID-19 is the ailment realized by an illness of the SARS-CoV-2 contamination, first perceived in the city ofWuhan, in China’s Hubei region in December 2019. COVID-19 was as of late known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) articulated the official name as COVID-19 in February 2020. Many drugs are being tried for coronavirus, but the favipiravir which was accepted for Chinese flu. The dynamic favipiravir restrains RNA polymerase and  forestalls replication of the viral genome, this is main work done by the favipiravir. In this review we will learn about how favipiravir can be used and its mechanism its mechanism of action and various trials that support that favipiravir can be medication for treatment of coronavirus.

Keywords: Favipiravir, World health organization, Coronavirus, Chinese flu.

How to cite : Hassan S A, Bhateja S , Arora G, Prathyusha F, Can favipiravir help in coronavirus treatment?. IP Int J Compr Adv Pharmacol 2020;5(2):73-76

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.